Clinical Trial Update: Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease [Phase 2, Phase 3]

View source ↗

Summary

The document reports on a phase 2/phase 3 clinical trial evaluating the safety and efficacy of tocilizumab in patients with myelin oligodendrocyte glycoprotein …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING